- Home
- AORT vs XZO Comparison
AORT vs XZO Comparison
Compare AORT & XZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AORT
- XZO
- Stock Information
- Founded
- AORT 1984
- XZO 2012
- Country
- AORT United States
- XZO United States
- Employees
- AORT N/A
- XZO N/A
- Industry
- AORT Medical/Dental Instruments
- XZO Property-Casualty Insurers
- Sector
- AORT Health Care
- XZO Finance
- Exchange
- AORT Nasdaq
- XZO Nasdaq
- Market Cap
- AORT 1.9B
- XZO 1.8B
- IPO Year
- AORT 1993
- XZO 2025
- Fundamental
- Price
- AORT $45.51
- XZO $15.40
- Analyst Decision
- AORT Strong Buy
- XZO
- Analyst Count
- AORT 5
- XZO 0
- Target Price
- AORT $49.36
- XZO N/A
- AVG Volume (30 Days)
- AORT 439.8K
- XZO 764.1K
- Earning Date
- AORT 11-06-2025
- XZO 01-01-0001
- Dividend Yield
- AORT N/A
- XZO N/A
- EPS Growth
- AORT N/A
- XZO N/A
- EPS
- AORT N/A
- XZO 0.45
- Revenue
- AORT $422,646,000.00
- XZO $183,708,000.00
- Revenue This Year
- AORT $14.91
- XZO N/A
- Revenue Next Year
- AORT $10.90
- XZO N/A
- P/E Ratio
- AORT N/A
- XZO $40.17
- Revenue Growth
- AORT 9.81
- XZO 302.33
- 52 Week Low
- AORT $21.97
- XZO $15.32
- 52 Week High
- AORT $48.04
- XZO $21.75
- Technical
- Relative Strength Index (RSI)
- AORT 54.81
- XZO N/A
- Support Level
- AORT $44.23
- XZO N/A
- Resistance Level
- AORT $48.04
- XZO N/A
- Average True Range (ATR)
- AORT 1.67
- XZO 0.00
- MACD
- AORT -0.13
- XZO 0.00
- Stochastic Oscillator
- AORT 38.77
- XZO 0.00
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.